Please Wait.....
Report
Ambulatory Surgery Center Market? By Center Type (Single Specialty Centers, Multispecialty Centers) , By Application (Gastroenterology, Ophthalmology, Orthopedics, Neurology, Others) By Modality (Hospital Based Ambulatory Surgical Center, Freestanding Ambulatory Surgical Center) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 216 Pages I Allied Market Research
Ambulatory Surgery Center Market
The ambulatory surgery center market was valued at $125.7 billion in 2023 and is projected to reach $229.6 billion by 2033, growing at a CAGR of 6.2% from 2024 to 2033.
Ambulatory surgical centers (ASCs) are the medical facilities that provide same-day surgical care, eliminating the requirement of overnight hospital admission. ASCs comprise cutting-edge medical technology and specialized surgical teams, ensuring high-quality care in a cost-effective manner as compared to conventional hospital-based surgeries. Orthopedic surgeries, ophthalmic surgeries, endoscopies, and cosmetic procedures are some of the common surgeries conducted in ASCs. ASCs are gradually becoming an important part of the healthcare system as they are enhancing the accessibility and efficiency in surgical care delivery.
The accessibility of undergoing surgeries cost effectively and in a short duration is boosting the demand for the establishment of ambulatory surgery centers. In addition, increase in the preference for outpatient care post surgeries due to fast recovery in familiar settings is a major factor augmenting the development of the ambulatory surgery center market. The trend of integrating telehealth services in ASCs is gaining prominence as the virtual care platforms facilitate the preoperative assessments and postoperative follow-ups. The platform enhances the accessibility of care for the patients by supporting the continuity of care during home recovery period.
However, a large base of individuals continues to prefer the conventional hospital settings for receiving healthcare services, hence restraining the development of the ambulatory surgery center market. In addition, limited infrastructure poses operation challenges for ASCs in the case of complex surgeries, which hampers market growth. Despite the challenges, the market is projected to expand in the future. Sg2, a Vizient company, released a "2023 Impact of Change Forecast" which anticipates ASCs and outpatient surgeries to witness growth in double digits over the next decade. As surgeries are shifting from traditional hospitals to ASCs, by 2033, outpatient surgical volumes are projected to reach 109.5 million cases, exhibiting an increase of 18%.
Segment Review
The ambulatory surgery center market is segmented into center type, application, modality, and region. On the basis of center type, the market is bifurcated into single specialty centers and multispecialty centers. Depending on application, it is divided into gastroenterology, ophthalmology, orthopedics, neurology, and others. As per modality, it is classified into hospital based ambulatory surgical center and freestanding ambulatory surgical center. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of center type, the single specialty centers segment dominates the market.
Depending on application, the orthopedic segment is the highest shareholder.
As per modality, the hospital based ambulatory surgical center segment is the highest shareholder in the ambulatory surgery center market.
Region wise, North America is the highest revenue generator.
Competition Analysis
The leading players operating in the global ambulatory surgery center market include CHSPSC, LLC, Edward-Elmhurst Health, Envision Healthcare Corporation, Healthway Medical Group, Nexus Day Surgery Centre, Pediatrix Medical Group, Prospect Medical Holdings, Inc., Surgery Partners, SurgCenter, and TH Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Reimbursement Scenario
Key Market Segments
By Center Type
- Single Specialty Centers
- Multispecialty Centers
By Application
- Gastroenterology
- Ophthalmology
- Orthopedics
- Neurology
- Others
By Modality
- Hospital Based Ambulatory Surgical Center
- Freestanding Ambulatory Surgical Center
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- CHSPSC, LLC
- Edward-Elmhurst Health
- Envision Healthcare Corporation
- Healthway Medical Group
- Nexus Day Surgery Centre
- Pediatrix Medical Group
- Prospect Medical Holdings, Inc.
- Surgery Partners
- SurgCenter
- TH Medical
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ANIMAL AIDS MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Medicinal Products
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Nutritional Supplements
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Diagnostic Products
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Surgical Equipment
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Wound Care Products
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
CHAPTER 5: ANIMAL AIDS MARKET, BY ANIMAL TYPE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Animal Type
5.2. Companion Animals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Livestock Animal
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Wildlife Animal.
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: ANIMAL AIDS MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Veterinary Clinics And Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Animal Shelters And Rescue Center
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Farms And Ranches
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Pet Owners
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: ANIMAL AIDS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product Type
7.2.3. Market Size and Forecast, By Animal Type
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Animal Aids Market
7.2.6.1. Market Size and Forecast, By Product Type
7.2.6.2. Market Size and Forecast, By Animal Type
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Animal Aids Market
7.2.7.1. Market Size and Forecast, By Product Type
7.2.7.2. Market Size and Forecast, By Animal Type
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Animal Aids Market
7.2.8.1. Market Size and Forecast, By Product Type
7.2.8.2. Market Size and Forecast, By Animal Type
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product Type
7.3.3. Market Size and Forecast, By Animal Type
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Animal Aids Market
7.3.6.1. Market Size and Forecast, By Product Type
7.3.6.2. Market Size and Forecast, By Animal Type
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Animal Aids Market
7.3.7.1. Market Size and Forecast, By Product Type
7.3.7.2. Market Size and Forecast, By Animal Type
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Animal Aids Market
7.3.8.1. Market Size and Forecast, By Product Type
7.3.8.2. Market Size and Forecast, By Animal Type
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Animal Aids Market
7.3.9.1. Market Size and Forecast, By Product Type
7.3.9.2. Market Size and Forecast, By Animal Type
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Animal Aids Market
7.3.10.1. Market Size and Forecast, By Product Type
7.3.10.2. Market Size and Forecast, By Animal Type
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Animal Aids Market
7.3.11.1. Market Size and Forecast, By Product Type
7.3.11.2. Market Size and Forecast, By Animal Type
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product Type
7.4.3. Market Size and Forecast, By Animal Type
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Animal Aids Market
7.4.6.1. Market Size and Forecast, By Product Type
7.4.6.2. Market Size and Forecast, By Animal Type
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Animal Aids Market
7.4.7.1. Market Size and Forecast, By Product Type
7.4.7.2. Market Size and Forecast, By Animal Type
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Animal Aids Market
7.4.8.1. Market Size and Forecast, By Product Type
7.4.8.2. Market Size and Forecast, By Animal Type
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Animal Aids Market
7.4.9.1. Market Size and Forecast, By Product Type
7.4.9.2. Market Size and Forecast, By Animal Type
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Animal Aids Market
7.4.10.1. Market Size and Forecast, By Product Type
7.4.10.2. Market Size and Forecast, By Animal Type
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Animal Aids Market
7.4.11.1. Market Size and Forecast, By Product Type
7.4.11.2. Market Size and Forecast, By Animal Type
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product Type
7.5.3. Market Size and Forecast, By Animal Type
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Animal Aids Market
7.5.6.1. Market Size and Forecast, By Product Type
7.5.6.2. Market Size and Forecast, By Animal Type
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Animal Aids Market
7.5.7.1. Market Size and Forecast, By Product Type
7.5.7.2. Market Size and Forecast, By Animal Type
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Animal Aids Market
7.5.8.1. Market Size and Forecast, By Product Type
7.5.8.2. Market Size and Forecast, By Animal Type
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Animal Aids Market
7.5.9.1. Market Size and Forecast, By Product Type
7.5.9.2. Market Size and Forecast, By Animal Type
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Zoetis Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Boehringer Ingelheim Animal Health
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Elanco Animal Health
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Merck Animal Health
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Bayer Animal Health
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. CEVA Sante Animale S.A.S.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Virbac
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Vetoquinol
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Dechra Pharmaceuticals Plc.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Phibro Animal Health Corporation.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 2. AMBULATORY SURGERY CENTER MARKET FOR SINGLE SPECIALTY CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. AMBULATORY SURGERY CENTER MARKET FOR MULTISPECIALTY CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 5. AMBULATORY SURGERY CENTER MARKET FOR GASTROENTEROLOGY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. AMBULATORY SURGERY CENTER MARKET FOR OPHTHALMOLOGY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. AMBULATORY SURGERY CENTER MARKET FOR ORTHOPEDICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. AMBULATORY SURGERY CENTER MARKET FOR NEUROLOGY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. AMBULATORY SURGERY CENTER MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. GLOBAL AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 11. AMBULATORY SURGERY CENTER MARKET FOR HOSPITAL BASED AMBULATORY SURGICAL CENTER, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. AMBULATORY SURGERY CENTER MARKET FOR FREESTANDING AMBULATORY SURGICAL CENTER, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. AMBULATORY SURGERY CENTER MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA AMBULATORY SURGERY CENTER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 17. NORTH AMERICA AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 18. U.S. AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 19. U.S. AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 20. U.S. AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 21. CANADA AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 22. CANADA AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 23. CANADA AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 25. MEXICO AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 26. MEXICO AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE AMBULATORY SURGERY CENTER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 29. EUROPE AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 30. EUROPE AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 31. FRANCE AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 32. FRANCE AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 33. FRANCE AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 34. GERMANY AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 35. GERMANY AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 36. GERMANY AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 37. ITALY AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 38. ITALY AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 39. ITALY AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 40. SPAIN AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 41. SPAIN AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 42. SPAIN AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 43. UK AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 44. UK AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 45. UK AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 47. REST OF EUROPE AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 48. REST OF EUROPE AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC AMBULATORY SURGERY CENTER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 51. ASIA-PACIFIC AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 52. ASIA-PACIFIC AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 53. CHINA AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 54. CHINA AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 55. CHINA AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 56. JAPAN AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 57. JAPAN AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 58. JAPAN AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 59. INDIA AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 60. INDIA AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 61. INDIA AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 62. SOUTH KOREA AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 63. SOUTH KOREA AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 64. SOUTH KOREA AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 65. AUSTRALIA AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 66. AUSTRALIA AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 67. AUSTRALIA AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 69. REST OF ASIA-PACIFIC AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 70. REST OF ASIA-PACIFIC AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA AMBULATORY SURGERY CENTER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 73. LAMEA AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 74. LAMEA AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 76. BRAZIL AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 77. BRAZIL AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 78. SOUTH AFRICA AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 79. SOUTH AFRICA AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 80. SOUTH AFRICA AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 81. SAUDI ARABIA AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 82. SAUDI ARABIA AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 83. SAUDI ARABIA AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 84. REST OF LAMEA AMBULATORY SURGERY CENTER MARKET, BY CENTER TYPE, 2024 - 2033 ($BILLION)
TABLE 85. REST OF LAMEA AMBULATORY SURGERY CENTER MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 86. REST OF LAMEA AMBULATORY SURGERY CENTER MARKET, BY MODALITY, 2024 - 2033 ($BILLION)
TABLE 87. CHSPSC, LLC: KEY EXECUTIVES
TABLE 88. CHSPSC, LLC: COMPANY SNAPSHOT
TABLE 89. CHSPSC, LLC: OPERATING SEGMENTS
TABLE 90. CHSPSC, LLC: PRODUCT PORTFOLIO
TABLE 91. CHSPSC, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92. EDWARD-ELMHURST HEALTH: KEY EXECUTIVES
TABLE 93. EDWARD-ELMHURST HEALTH: COMPANY SNAPSHOT
TABLE 94. EDWARD-ELMHURST HEALTH: OPERATING SEGMENTS
TABLE 95. EDWARD-ELMHURST HEALTH: PRODUCT PORTFOLIO
TABLE 96. EDWARD-ELMHURST HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 97. ENVISION HEALTHCARE CORPORATION: KEY EXECUTIVES
TABLE 98. ENVISION HEALTHCARE CORPORATION: COMPANY SNAPSHOT
TABLE 99. ENVISION HEALTHCARE CORPORATION: OPERATING SEGMENTS
TABLE 100. ENVISION HEALTHCARE CORPORATION: PRODUCT PORTFOLIO
TABLE 101. ENVISION HEALTHCARE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 102. HEALTHWAY MEDICAL GROUP: KEY EXECUTIVES
TABLE 103. HEALTHWAY MEDICAL GROUP: COMPANY SNAPSHOT
TABLE 104. HEALTHWAY MEDICAL GROUP: OPERATING SEGMENTS
TABLE 105. HEALTHWAY MEDICAL GROUP: PRODUCT PORTFOLIO
TABLE 106. HEALTHWAY MEDICAL GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107. NEXUS DAY SURGERY CENTRE: KEY EXECUTIVES
TABLE 108. NEXUS DAY SURGERY CENTRE: COMPANY SNAPSHOT
TABLE 109. NEXUS DAY SURGERY CENTRE: OPERATING SEGMENTS
TABLE 110. NEXUS DAY SURGERY CENTRE: PRODUCT PORTFOLIO
TABLE 111. NEXUS DAY SURGERY CENTRE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112. PEDIATRIX MEDICAL GROUP: KEY EXECUTIVES
TABLE 113. PEDIATRIX MEDICAL GROUP: COMPANY SNAPSHOT
TABLE 114. PEDIATRIX MEDICAL GROUP: OPERATING SEGMENTS
TABLE 115. PEDIATRIX MEDICAL GROUP: PRODUCT PORTFOLIO
TABLE 116. PEDIATRIX MEDICAL GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117. PROSPECT MEDICAL HOLDINGS, INC.: KEY EXECUTIVES
TABLE 118. PROSPECT MEDICAL HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 119. PROSPECT MEDICAL HOLDINGS, INC.: OPERATING SEGMENTS
TABLE 120. PROSPECT MEDICAL HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 121. PROSPECT MEDICAL HOLDINGS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 122. SURGERY PARTNERS: KEY EXECUTIVES
TABLE 123. SURGERY PARTNERS: COMPANY SNAPSHOT
TABLE 124. SURGERY PARTNERS: OPERATING SEGMENTS
TABLE 125. SURGERY PARTNERS: PRODUCT PORTFOLIO
TABLE 126. SURGERY PARTNERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127. SURGCENTER: KEY EXECUTIVES
TABLE 128. SURGCENTER: COMPANY SNAPSHOT
TABLE 129. SURGCENTER: OPERATING SEGMENTS
TABLE 130. SURGCENTER: PRODUCT PORTFOLIO
TABLE 131. SURGCENTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132. TH MEDICAL: KEY EXECUTIVES
TABLE 133. TH MEDICAL: COMPANY SNAPSHOT
TABLE 134. TH MEDICAL: OPERATING SEGMENTS
TABLE 135. TH MEDICAL: PRODUCT PORTFOLIO
TABLE 136. TH MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL AMBULATORY SURGERY CENTER MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF AMBULATORY SURGERY CENTER MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN AMBULATORY SURGERY CENTER MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALAMBULATORY SURGERY CENTER MARKET
FIGURE 10. GLOBAL AMBULATORY SURGERY CENTER MARKET SEGMENTATION, BY CENTER TYPE
FIGURE 11. AMBULATORY SURGERY CENTER MARKET FOR SINGLE SPECIALTY CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. AMBULATORY SURGERY CENTER MARKET FOR MULTISPECIALTY CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL AMBULATORY SURGERY CENTER MARKET SEGMENTATION, BY APPLICATION
FIGURE 14. AMBULATORY SURGERY CENTER MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. AMBULATORY SURGERY CENTER MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. AMBULATORY SURGERY CENTER MARKET FOR ORTHOPEDICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. AMBULATORY SURGERY CENTER MARKET FOR NEUROLOGY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. AMBULATORY SURGERY CENTER MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. GLOBAL AMBULATORY SURGERY CENTER MARKET SEGMENTATION, BY MODALITY
FIGURE 20. AMBULATORY SURGERY CENTER MARKET FOR HOSPITAL BASED AMBULATORY SURGICAL CENTER, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. AMBULATORY SURGERY CENTER MARKET FOR FREESTANDING AMBULATORY SURGICAL CENTER, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 26. COMPETITIVE DASHBOARD
FIGURE 27. COMPETITIVE HEATMAP: AMBULATORY SURGERY CENTER MARKET
FIGURE 28. TOP PLAYER POSITIONING, 2023
FIGURE 29. CHSPSC, LLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 30. CHSPSC, LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 31. CHSPSC, LLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 32. EDWARD-ELMHURST HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 33. EDWARD-ELMHURST HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 34. EDWARD-ELMHURST HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 35. ENVISION HEALTHCARE CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 36. ENVISION HEALTHCARE CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 37. ENVISION HEALTHCARE CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 38. HEALTHWAY MEDICAL GROUP: NET SALES, 2021-2023 ($BILLION)
FIGURE 39. HEALTHWAY MEDICAL GROUP: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 40. HEALTHWAY MEDICAL GROUP: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 41. NEXUS DAY SURGERY CENTRE: NET SALES, 2021-2023 ($BILLION)
FIGURE 42. NEXUS DAY SURGERY CENTRE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 43. NEXUS DAY SURGERY CENTRE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 44. PEDIATRIX MEDICAL GROUP: NET SALES, 2021-2023 ($BILLION)
FIGURE 45. PEDIATRIX MEDICAL GROUP: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 46. PEDIATRIX MEDICAL GROUP: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 47. PROSPECT MEDICAL HOLDINGS, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 48. PROSPECT MEDICAL HOLDINGS, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 49. PROSPECT MEDICAL HOLDINGS, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 50. SURGERY PARTNERS: NET SALES, 2021-2023 ($BILLION)
FIGURE 51. SURGERY PARTNERS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 52. SURGERY PARTNERS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 53. SURGCENTER: NET SALES, 2021-2023 ($BILLION)
FIGURE 54. SURGCENTER: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 55. SURGCENTER: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 56. TH MEDICAL: NET SALES, 2021-2023 ($BILLION)
FIGURE 57. TH MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 58. TH MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security